Management of High Blood Pressure in African Americans<subtitle>Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks</subtitle>

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1993 • 28,274 citations

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

2003 • 25,662 citations

Prediction of Coronary Heart Disease Using Risk Factor Categories

1998 • 9,392 citations

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

2000 • 8,612 citations

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

2001 • 7,165 citations

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

1998 • 6,576 citations

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

2001 • 5,812 citations

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

1998 • 5,793 citations

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1997 • 5,689 citations

A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure

1997 • 5,637 citations

Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

1990 • 5,586 citations

Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

2002 • 5,558 citations

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

2002 • 5,471 citations

The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

1993 • 5,296 citations

Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet

2001 • 5,241 citations

Physical Activity and Health: A Report of the Surgeon General

1995 • 5,036 citations

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

1998 • 4,813 citations

ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations

2000 • 4,662 citations

1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension

1999 • 3,718 citations

Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions

1992 • 3,708 citations

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

2001 • 3,093 citations

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

2001 • 3,065 citations

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension

1997 • 2,965 citations

Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group.

1988 • 2,106 citations

Validation of the Framingham Coronary Heart Disease Prediction Scores

2001 • 2,076 citations

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

1998 • 2,024 citations

Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>

2002 • 1,983 citations

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials

2000 • 1,789 citations

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

2001 • 1,774 citations

A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction

1995 • 1,734 citations

Blood Pressure and End-Stage Renal Disease in Men

1996 • 1,639 citations

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

2002 • 1,592 citations

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1999 • 1,472 citations

AHA Dietary Guidelines

2000 • 1,452 citations

Preserving renal function in adults with hypertension and diabetes: A consensus approach

2000 • 1,406 citations

Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations

1999 • 1,333 citations

Intersalt: An international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion

1988 • 1,291 citations

The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension

1998 • 1,166 citations

A general cardiovascular risk profile: The Framingham study

1976 • 1,165 citations

Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study

2001 • 1,063 citations

Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group.

1988 • 1,059 citations

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

2000 • 1,050 citations

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

1999 • 945 citations

Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2001 • 931 citations

Health Outcomes Associated With Antihypertensive Therapies Used as First-Line Agents<subtitle>A Systematic Review and Meta-analysis</subtitle>

1997 • 887 citations

Long-Term Weight Loss and Changes in Blood Pressure: Results of the Trials of Hypertension Prevention, Phase II

2001 • 872 citations

Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM

1998 • 856 citations

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

2002 • 848 citations

Exercise standards. A statement for health professionals from the American Heart Association.

1990 • 751 citations

Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature

1996 • 728 citations

Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

2000 • 688 citations

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity

2001 • 636 citations

Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation

1999 • 591 citations

Systolic and Diastolic Blood Pressure, Pulse Pressure, and Mean Arterial Pressure as Predictors of Cardiovascular Disease Risk in Men

2000 • 566 citations

Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular Dysfunction

2001 • 558 citations

Exercise Standards

1995 • 556 citations

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

2002 • 545 citations

Obesity and Heart Disease

1997 • 536 citations

Physician-Related Barriers to the Effective Management of Uncontrolled Hypertension

2002 • 507 citations

Treatment of Hypertension in Adults With Diabetes

2003 • 502 citations

Prevention Conference V

2000 • 471 citations

Calcium-Antagonist Drugs

1999 • 439 citations

Aspirin as a Therapeutic Agent in Cardiovascular Disease

1997 • 437 citations

Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy

1996 • 427 citations

Association Between Blood Pressure Level and the Risk of Myocardial Infarction, Stroke, and Total Mortality

2001 • 420 citations

Importance of Systolic Blood Pressure in Older Americans

2000 • 410 citations

ACC/AHA/ACP–ASIM Guidelines for the Management of Patients With Chronic Stable Angina: Executive Summary and Recommendations

1999 • 362 citations

Elevated systolic blood pressure as a cardiovascular risk factor

2000 • 356 citations

Elevated systolic blood pressure and risk of cardiovascular and renal disease: Overview of evidence from observational epidemiologic studies and randomized controlled trials

1999 • 320 citations

Normotensive Salt Sensitivity

1999 • 318 citations

Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema*

1996 • 314 citations

Race and the Response to Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure

2001 • 300 citations

Rationale for Fixed-Dose Combinations in the Treatment of Hypertension

2002 • 299 citations

Effects of Reduced Sodium Intake on Hypertension Control in Older Individuals

2001 • 277 citations

Long-term Effects of Antihypertensive Agents on Proteinuria and Renal Function

1995 • 272 citations

A Comparison of the Efficacy and Safety of a β-Blocker, a Calcium Channel Blocker, and a Converting Enzyme Inhibitor in Hypertensive Blacks

1990 • 263 citations

Black-White Inequalities in Mortality and Life Expectancy, 1933–1999: Implications for Healthy People 2010

2001 • 251 citations

Evaluation of the Insulin Resistance Syndrome in 5- to 10-Year-Old Overweight/Obese African-American Children

2001 • 237 citations

Microalbuminuria in Nondiabetic Adults

1998 • 233 citations

Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients

2003 • 225 citations

Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy

1999 • 181 citations

Regional and Racial Differences in Response to Antihypertensive Medication Use in a Randomized Controlled Trial of Men With Hypertension in the United States

2000 • 170 citations

Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.

1997 • 167 citations

Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

2002 • 161 citations

Effect of Calcium Channel or β-Blockade on the Progression of Diabetic Nephropathy in African Americans

1997 • 151 citations

A Multifactorial Trial Design to Assess Combination Therapy in Hypertension

1994 • 150 citations

Effects of Blood Pressure Control on Progressive Renal Disease in Blacks and Whites

1997 • 150 citations

Effect of Beta-Blockade on Mortality Among High-Risk and Low-Risk Patients After Myocardial Infarction

1999 • 143 citations

Antecedent Blood Pressure and Risk of Cardiovascular Disease

2002 • 142 citations

Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.

1999 • 138 citations

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension

2002 • 137 citations

Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension

2000 • 131 citations

High Blood Pressure and Diabetes Mellitus

2000 • 131 citations

Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension

1999 • 125 citations

Dietary Electrolytes and Blood Pressure

1998 • 122 citations

Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial

2001 • 120 citations

Racial differences of parameters associated with blood pressure levels in children—The Bogalusa Heart Study

1979 • 112 citations

Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals

1997 • 104 citations

Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients

2001 • 103 citations

Comparison of Amlodipine and Benazepril Monotherapy to Amlodipine Plus Benazepril In Patients with Systemic Hypertension: A Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study

1995 • 95 citations

Increased sensitivity to bradykinin among African Americans

1996 • 92 citations

Maximizing Cardiorenal Benefit in the Management of Hypertension: Achieve Blood Pressure Goals.

1999 • 79 citations

Effect of race on hypertension and antihypertensive therapy

2000 • 71 citations

A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides

1996 • 67 citations

Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives: relation to salt intake

2001 • 65 citations

Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension

2001 • 63 citations

Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: The experience with the Beta Blocker Heart Attack Trial

1984 • 62 citations

Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects

1996 • 60 citations

Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough

2000 • 57 citations

End-stage Renal Disease in Specific Ethnic and Racial Groups

1998 • 53 citations

Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension

2001 • 52 citations

Fixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluation

1999 • 48 citations

Use of the Factorial Design and Quadratic Response Surface Models to Evaluate the Fosinopril and Hydrochlorothiazide Combination Therapy in Hypertension

1997 • 47 citations

Type 2 Diabetes: RENAAL and IDNT—The Emergence of New Treatment Options

2002 • 45 citations

Using Angiotensin Converting Enzyme Inhibitors in African-American Hypertensives: A New Approach to Treating Hypertension and Preventing Target-Organ Damage

2000 • 40 citations

New salt-sensitivity metrics: variability-adjusted blood pressure change and the urinary sodium-to-creatinine ratio.

2002 • 39 citations

The African American Study of Kidney Disease and Hypertension (AASK): New Findings

2001 • 32 citations

Changing Trends in Angioedema

2001 • 31 citations

Safety and Efficacy of Amlodipine Added to Hydrochlorothiazide Therapy in Essential Hypertension

1989 • 30 citations

Use of β ‐ Adrenergic Receptor Blockers in Blacks

1996 • 26 citations

Nitrendipine and Enalapril Combination Therapy in Mild to Moderate Hypertension: Assessment of Dose-Response Relationship by a Clinical Trial of Factorial Design

2001 • 23 citations

Combined Therapy with Benazepril and Amlodipine in the Treatment of Hypertension Inadequately Controlled by an ACE Inhibitor Alone

1997 • 22 citations

Lessons from combination therapy in veterans affairs studies

1996 • 21 citations

Racial differences in ambulatory blood pressure monitoring-derived 24 h patterns of blood pressure in adolescents

1999 • 21 citations

Salt intake and hypertensive renal injury in African-Americans a therapeutic perspective

1995 • 20 citations

Efficacy and Safety of Various Combination Therapies Based on a Calcium Antagonist in Essential Hypertension

1993 • 19 citations

Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney disease and hypertension pilot study

1996 • 17 citations

Hypertension in African Americans: a paradigm of metabolic disarray.

1996 • 15 citations

Treatment of Patients with Essential Hypertension and Microalbuminuria

1997 • 6 citations

Public Health Aspects of Out-of-Hospital Sudden Cardiac Arrest Among Elderly African-Americans.

1997 • 5 citations

Are calcium antagonists effective in preventing complications of hypertension and progression of renal disease?

2000 • 5 citations